Pharmacovigilance
Department Insights
Sri Venkateswara Institute of Medical
Sciences, Tirupati
Adverse Drug
Reaction Monitoring Centre (AMC)
Sri Venkateswara Institute of Medical
Sciences, Tirupati, recognized as an Adverse Drug Reaction
Monitoring Centre (AMC) and approved by the Indian
Pharmacopoeia Commission – National Coordinating Centre (PvPI),
Ghaziabad on 08/07/2015, plays a crucial role in safeguarding
patient health by systematically monitoring, assessing, and
responding to adverse drug reactions (ADRs). With a
multidisciplinary team and a strong governance structure, our
aim is to enhance the safety and efficacy of medicinal use
across the institution.
Objectives of the Pharmacovigilance
Committee:
-
Monitor and document adverse drug
reactions (ADRs) in inpatient and outpatient settings.
-
Promote awareness and education on drug
safety among healthcare professionals.
-
Encourage timely and accurate reporting
of ADRs by clinicians, nursing staff, and pharmacists.
-
Analyze data to identify trends, evaluate
risk factors, and recommend interventions.
-
Collaborate with the Pharmacovigilance
Programme of India (PvPI) and other regulatory bodies.
-
Conduct regular training, workshops, and
continuing medical education (CME) programs on
pharmacovigilance.
Key Activities:
·
Collection, analysis, and causality assessment
of ADR reports from all clinical departments.
·
Conducting monthly Pharmacovigilance
Committee meetings to review and discuss the ADRs collected
throughout the month.
·
Monthly meetings are held to perform
causality assessment of the ADRs by committee experts.
·
Organizing awareness programs and
pharmacovigilance workshops for medical and nursing staff.
·
Publishing safety bulletins and updates
regarding drug reactions and recalls.
·
Promoting student and intern participation in
pharmacovigilance practices.
·
Ensuring confidentiality, integrity, and proper
documentation of pharmacovigilance data.
Leadership & Team (PVC Members):
|
S. No |
Name of the Faculty |
Designation |
PVC Role |
|
01 |
Dr. Usha Kalawat |
Principal |
Chairman |
|
02 |
Dr. R. Ram |
Professor & HOD of
Nephrology |
Co-Chairman |
|
03 |
Dr. K. Umamaheswara
Rao |
Professor & HOD of
Pharmacology |
Co-ordinator |
|
04 |
Dr. C. Pallavi |
Associate Professor
of Pharmacology |
Deputy Co-ordinator |
|
05 |
Dr. K. ChandraSekhar |
Assistant Professor
of Medicine |
Member |
|
06 |
Dr. Y. Mutheeswaraiah |
Professor & HOD of
General Surgery |
Member |
|
07 |
Dr. K. Vijaya Chandra
Reddy |
Professor of
Pharmacology |
Member |
|
08 |
Dr. Punith Patak |
Professor & HOD of
Paediatrics |
Member |
|
09 |
Dr. A. Surekha |
Associate Professor &
I/C HOD, Dermatology |
Member |
|
10 |
Mrs. Prabhavathi |
D.D. Nursing |
Member |
Junior
Pharmacovigilance Associate:
Mrs. M.K. Manisha, M. Pharm, appointed by the Indian
Pharmacopoeia Commission – National Coordinating Centre (PvPI),
Ghaziabad.
Our Commitment:
At SVIMS, pharmacovigilance is not just a
regulatory obligation—it is a critical element of clinical
care. Through constant vigilance, education, and
collaboration, we aim to minimize drug-related harm and
continuously improve the standards of patient safety and
public health.
***
Medical Device Adverse Event Monitoring Centre
